Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma.

Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor. Sci Rep (2016) 0.82

Solar Simulated Ultraviolet Radiation Induces Global Histone Hypoacetylation in Human Keratinocytes. PLoS One (2016) 0.76

Global histone modification patterns predict risk of prostate cancer recurrence. Nature (2005) 7.03

Chemical phylogenetics of histone deacetylases. Nat Chem Biol (2010) 4.36

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature (2012) 2.96

Adenovirus small e1a alters global patterns of histone modification. Science (2008) 2.43

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol (2010) 1.57

Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management. Am J Hematol (2012) 1.54

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood (2010) 1.53

Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression. Mol Cell Biol (2006) 1.46

c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Mol Cell (2007) 1.40

Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell (2013) 1.35

A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science (2013) 1.32

Mutational analysis of H3 and H4 N termini reveals distinct roles in nuclear import. J Biol Chem (2007) 1.21

HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells. Leukemia (2010) 1.15

HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J Clin Invest (2013) 1.02

The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases. J Biol Chem (2013) 0.89

Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. Leukemia (2013) 0.92

A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation. Blood Cancer J (2014) 0.80

Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation. Blood Cancer J (2015) 0.78